How can POCT benefit healthcare professionals in diagnosing and managing diabetes and comorbidities?
Join our panel of experts from around the world - USA, Japan and Switzerland - to learn how they use point of care testing for the management of their patients with diabetes and comorbidities.
This webinar will be chaired by Dr. Vivian Fonseca, an endocrinology, diabetes & metabolism specialist in Metairie, Louisiana, USA. He is current Chief, Endocrinology at the Tulane University School of Medicine.
Dr. Fonseca will start the webinar with his talk about the benefits HbA1c POC testing may provide.
Dr. Yasuhiro Iijima is diabetologist and director at the Fujiyasu Clinic and works also at the Department of Diabetes Metabolism and Endocrinology at Tokyo Medical University, Japan. Dr. Iijima will present his experience with POC lipid testing.
PD Dr. Andreas Kistler is Department Chief of Internal Medicine at the Kantonsspital Frauenfeld in Zurich, Switzerland. Dr. Kistler will share which impact the availability of ACR testing at the point-of-Care has on the identification and management of kidney disease.
Dr. Vivian Fonseca
The Value of point-of-care testing in Diabetes
PD Dr. Andreas David Kistler
Relevance of determining albuminuria in the practice
Dr. Yasuhiro Iijima
Immediate lipid testing with POC is effective and attractive for the treatment and education of outpatients
Live stream will be held in English, Japanese, Spanish, Brazilian-Portuguese, German and Italian. Available on demand in two additional languages: French and Korean.
As opiniões e opiniões apresentadas são apenas dos autores. O conteúdo deste webcast destina-se apenas a fins informativos/educativos.
© 2023 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Products available in select markets only. COL-00000